Intelligence Platform
Patents
Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6569431
Recombinant antibody fragments as autoantibody antagonists
expired patentUS 6566342
Gene therapy by secretory gland expression
expired patentUS 6566326
Chemically modified hemoglobin for burn shock resuscitation
expired patentUS 6566324
Preventing airway mucus production by administration of EGF-R antagonists
expired patentUS 6565889
Bilayer structure which encapsulates multiple containment units and uses thereof
expired patentUS 6562819
Compounds for inhibition of ceramide-mediated signal transduction
expired patentUS 6562606
Methods and compositions for disrupting the epithelial barrier function
expired patentUS 6558668
Methods for detection and treatment of neural cancers
expired patentUS 6555582
Eye treatments using synthetic thyroid hormone compositions
expired patentUS 6555347
Human minor vault protein p193
expired patentUS 6555116
Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
expired patentUS 6551989
Preventing airway mucus production by administration of EGF-R antagonists
expired patentUS 6551588
Tumor radiosensitization using gene therapy
expired patentUS 6548679
Antitumor agents
expired patentUS 6548521
Inhibitors of metazoan parasite proteases
expired patentUS 6545034
Use of etodolac for the treatment of chronic lymphocytic leukemia
expired patentUS 6544956
Lunasin peptides
expired patentUS 6544757
Synthesis of human virus antigens by yeast
expired patentUS 6541195
Correction of genetic defects using chemical chaperones
expired patentUS 6541212
Methods for detecting prostate stem cell antigen protein
expired patentUS 6537768
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof,
expired patentUS 6534310
Suppression of proteolytic activity by dysfunctional protease formation
expired patentUS 6534283
Method for treatment and prevention of physiological shock
expired patentUS 6534062
Methods for increasing a cytotoxic T lymphocyte response in vivo
expired